King Luther Capital Management Corp Gilead Sciences, Inc. Transaction History
King Luther Capital Management Corp
- $23 Billion
- Q3 2024
A detailed history of King Luther Capital Management Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, King Luther Capital Management Corp holds 8,903 shares of GILD stock, worth $802,961. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,903
Previous 11,285
21.11%
Holding current value
$802,961
Previous $774,000
3.62%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding GILD
# of Institutions
1,923Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.4 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.9 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.57 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.43 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $113B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...